Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gefitinib in Advanced Bronchioloalveolar Carcinoma
NCT00029003Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Dec 2001
- Primary completion
- Dec 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of gefitinib in bronchioloalveolar carcinoma (BAC), sponsored by National Cancer Institute. Started Dec 2001; status: completed.
02
Drugs
03
Conditions
bronchioloalveolar carcinoma (BAC)
Beyond the preview
Go deeper on NCT00029003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00029003.